RetinalGeniX Technologies Inc (RTGN)

[jfk]

Dropping like a rock. Nothing to hold it up in a weaker trending biotech market overall. Wonder when they start to attend shows and start to prop this up.

[stocktrademan]

$RTGN recent news/filings

bullish

basic chart ## source: stockcharts.com



basic chart ## source: stockscores.com



big daily chart ## source: stockcharts.com



big weekly chart ## source: stockcharts.com



$RTGN DD Notes ~ http://www.ddnotesmaker.com/RTGN

## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/RTGN/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/RTGN/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=RTGN+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=RTGN+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=RTGN+Industry

## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/RTGN/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/RTGN/news - http://finance.yahoo.com/q/h?s=RTGN+Headlines

## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/RTGN/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/RTGN/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/RTGN/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/RTGN/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/RTGN/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/RTGN/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/RTGN/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/RTGN/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=RTGN+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/RTGN
DTCC (dtcc.com): http://search2.dtcc.com/?q=Apple%2C+Inc.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Apple%2C+Inc.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Apple%2C+Inc.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.apple.com/pr
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.apple.com/pr#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.apple.com/pr

## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/RTGN/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/RTGN
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/RTGN/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/RTGN/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/RTGN/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0000320193&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/RTGN/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/RTGN/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/RTGN/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/RTGN/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=RTGN&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=RTGN
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/RTGN/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=RTGN+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=RTGN+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=RTGN
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=RTGN
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=RTGN+RTGNh+Flow&annual

## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/RTGN/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=RTGN+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/RTGN.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=RTGN
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/RTGN/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/RTGN/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/RTGN/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/RTGN/insider-transactions

## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/RTGN
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/RTGN
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/RTGN:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=RTGN
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=RTGN
StockTwits (stocktwits.com): http://stocktwits.com/symbol/RTGN

$RTGN DD Notes ~ http://www.ddnotesmaker.com/RTGN

[RealGenius]

Company now Pulmatrix
We design and develop inhaled therapeutic products based on our proprietary dry powder delivery technology, iSPERSE (inhaled Small Particles Easily Respirable and Emitted), which enables delivery of small or large molecule drugs to the lungs by inhalation for local or systemic applications. We are developing iSPERSE-based therapeutic candidates targeted at prevention and treatment of a range of respiratory diseases, targeting chronic obstructive pulmonary disease (COPD) and rare/orphan indications including cystic fibrosis (CF), and idiopathic pulmonary fibrosis (IPF).

[rtraster]

ARTICLE: Small Cap Guru Reveals A 9.9% Position In Ruthigen Inc. (RTGN)
Small-cap company Ruthigen Inc (RTGN) has hit our radar this week with the announcement of a significant new shareholder.

...leading Interclick to a $270 million buyout from Yahoo! (YHOO) in 2011...

Article refers to SEC Form 13G posted yesterday, new 9.9% stake by very shareholder-friendly, activist institutional investor.
http://www.sec.gov/Archives/edgar/data/1574235/000141588915001951/0001415889-15-001951-index.htm

[rtraster]

Activist investor takes 9.9% stake in Ruthigen
Statement of acquisition of beneficial ownership
9.9%
Just posted!
http://www.sec.gov/Archives/edgar/data/1574235/000141588915001951/0001415889-15-001951-index.htm

[jimsgotweb]

The outcome of the clinical trials is interesting because of the high rate of infection associated with abdominal surgery.

[lewsogge]

Merger announcement coming 3/12? http://ih.advfn.com/p.php?pid=nmona&article=65062802

[jfk]

2 million shares wil be bought at merger at price of $2.75. Unless they are locked-up, unlikely for long, I am concerned that $2.75 may be the cap for this stock for YEARS! 2 million shares is a huge percent of the float. Who will buy this 2 million once it begins to get unloaded?

[goldia]

Moving up day for day...

Merger News ahead imo.

[goldia]

Yeah, nice green today....News ?

[goldia]

Upstairs !

[goldia]

Nice close today.

[~S.B.A.~]

Theres been a buyer methodically buying down here.

[goldia]

No news yet, but nice move.

[goldia]

Some good news and the train is leaving...

[~S.B.A.~]

Good vol day

[~S.B.A.~]

Emerging infectious disease theme

[~S.B.A.~]

Heavy volume today. Wish the company would put something out and capitalize on emerging infectious disease trend. 2.6 million float the company would erupt

[onewhoknows2much]

Yeah you would think that a big and timely opportunity for sure.

[~S.B.A.~]

I would like the company to be more vocal and capitalize on national/global themes ie Ebola, Antibiotic resistance, HAIs, ect...

[onewhoknows2much]

Gotcha...TY!

[~S.B.A.~]

SANTA ROSA, Calif., July 17, 2014 /PRNewswire/ -- Ruthigen, Inc., (RTGN) today announced that it has treated the first human subjects with its leading drug candidate RUT58-60 in a 30 patient, 21-day skin irritation trial, which is expected to be completed in August 2014.

[onewhoknows2much]

Still expecting data on the 7th? What are we looking for?

[~S.B.A.~]

August 7th data. Averaged down here. Chart looks like it might erupt in in August.

[~S.B.A.~]

August 7th expect DATA

[~S.B.A.~]

http://seekingalpha.com/article/2288933-ruthigen-poised-to-hit-it-out-of-the-park

[~S.B.A.~]

Coverage initiated PT: $12

[~S.B.A.~]

Nice volume charts setting up

[onewhoknows2much]

He and Honig have a very well documented track record of success for sure.

[~S.B.A.~]

Rumors of Frost is one of the reasons i've loaded up here. Just alone his presence could double the stock. He's already cornered the infectious market in past ventures.

[onewhoknows2much]

I believe he has a large position. That is my understanding as well. Value is here, just need more investors to be aware of that value.

[~S.B.A.~]

We should see some PRs heading into July. One poster eluded to dr Frost filing sg13 which seems to be rumor. To note Barry Honig owns 8% here who parallel invests w/ Frost on many of ventuers

[onewhoknows2much]

and they had news out this am...yet nobody appears to be paying any attention. Still trying to be patient.

[~S.B.A.~]

chart looks good

[~S.B.A.~]

Antibiotic Resistance & Trans-Atlantic Trade - Congressional Briefing 5/30/14

[~S.B.A.~]

Barry Honig & Dr.Frost past deals $OPK $TEVA $CDXC $MSLP
Honig's RECENT SG(13) 8.25% in $RTGN. I'm betting this is Dr. Frost's next venture.

[~S.B.A.~]

Not much selling shows those running the stock are waiting for a catalyst. I believe the communication will start when IND response is materialized next week. May 2nd filing +30 days.

Current construction of a W-formation with a neck-line of 7.00.

[onewhoknows2much]

I bid the stock all day Friday with 3k at 6.18 trying to add. No such luck, nobody willing to hit me. I think it's only a matter of time before we get some communication or progress that will create value.

[~S.B.A.~]

IND response next week. IND filed May 2nd +30 day process w/ FDA. Any sort of news could send this low float (2.5million) on a run.

[onewhoknows2much]

Can't happen soon enough. Stock is again under some pressure and trading at below fair value in my opinion.

[~S.B.A.~]

"initiate patient enrollment for its combined Phase 1/2 clinical trial in the prevention of infection post abdominal surgery for RUT58-60 in July 2014"

Would make sense for an IR/PR campaign to start in that timeframe

[~S.B.A.~]

IND FDA response next week.

[~S.B.A.~]

World Health Assembly closes

News release

24 MAY 2014 | GENEVA - The Sixty-seventh World Health Assembly closed today, after adopting more than 20 resolutions on public health issues of global importance.

“This has been an intense Health Assembly, with a record-breaking number of agenda items, documents and resolutions, and nearly 3 500 registered delegates,” said Dr Margaret Chan, WHO’s Director-General. “This is a reflection of the growing number of complexity of health issues, and your deep interest in addressing them.”

A number of the Health Assembly resolutions were approved today on the following issues.

Antimicrobial drug resistance

The delegates recognized their growing concern of antimicrobial resistance and urged governments to strengthen national action and international collaboration. This requires sharing information on the extent of resistance and the use of antibiotics in humans and animals. It also involves improving awareness among health providers and the public of the threat posed by resistance, the need for responsible use of antibiotics, and the importance of good hand hygiene and other measures to prevent infections.

The resolution urges Member States to strengthen drug management systems, to support research to extend the lifespan of existing drugs, and to encourage the development of new diagnostics and treatment options.

As requested in the resolution, WHO will develop a draft global action plan to combat antimicrobial resistance, including antibiotic resistance for presentation to the World Health Assembly for approval next year.

http://www.who.int/mediacentre/news/releases/2014/WHA-20140524/en/

[~S.B.A.~]

Good to see volume. Company needs PR/IR to capitalize on antibiotic resistance. I would imagine with a new issue an IR/PR plan has already been established. Question is when will we see the rollout of such plans?

[onewhoknows2much]

Company sill not saying anything to help it's own cause which defies reason. Hopefully that soon changes.

[~S.B.A.~]

6.83 close very nice hopefully we'll see momentum and break the 7r neckline near term. The amount of shares in the float is micro 2.5million. Enables any move to glide

[onewhoknows2much]

Gotcha, thanks.

[~S.B.A.~]

I do not, but i would assume an IR plan has already been developed. The question is when does the IR plan become initiated. The WHO report is around 25 days old, and the national pressers started debuting stories 20 days ago. Seems like we are still earlier in this trend as retail is obvious.

[onewhoknows2much]

I would agree. Do you have any contact with their IR or anyone at the company? Would be nice of them to capitalize on the current state of affairs out in the press. Huge opportunity to get front and center one would think.

[~S.B.A.~]

Charts solid for a next leg up. Would be in the company's best interest in taking advantage of the antibiotic resistance crisis theme which is debuting on the national press.